VTVT

NASDAQStock

vTv Therapeutics Inc.

$33.01-0.70 (-2.09%)

52-Week Range

$14.00

$42.72

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.43

Volume

138.1K

Avg Volume

68.5K

Performance

-7.62%

-0.15%

+65.16%

YTD

-14.87%

+127.00%

+6.65%

-69.58%

Price Chart

ETF Exposure

VTVT is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.01%	3,645	$128K	$1.27B	0.60%
VXF	Vanguard Extended Market ETF	0.00%	31,515	$1.1M	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	3	$175	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	130	$6K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$30	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	74,346	$2.6M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	391	$19K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	33	$2K	$1.29B	0.17%

About VTVT ETF Exposure

vTv Therapeutics Inc. (VTVT) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $33.01. Investors can gain exposure to VTVT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VTVT, sorted by portfolio weight.